Utilizing network pharmacology to explore potential mechanisms of YiSui NongJian formula in treating myelodysplastic syndrome

Utilizing network pharmacology to explore potential mechanisms of YiSui NongJian formula in treating myelodysplastic syndrome

The study aims to explore potential mechanisms of YiSui NongJian formula (YSNJF) in treating myelodysplastic syndromes (MDS) by network pharmacology-based strategy. Active compounds and corresponding potential therapeutic targets of YSNJF were harvested by utilizing the database of TCMSP (Traditiona...

Full description

Bibliographic Details
Main Authors:	Lerong Qin, Haiyan Chen, Xiaoqing Ding, Ming Guo, Haiyan Lang, Junxia Liu, Ling Li, Jing Liao, Junyao Liao
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	Bioengineered
Subjects:	yisui nongjian formula network pharmacology myelodysplastic syndrome
Online Access:	http://dx.doi.org/10.1080/21655979.2021.1933867

Similar Items

Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model
by: Zhang E, et al.
Published: (2016-09-01)

Effect of klotho as an ageing suppressor on insulin signalling cascade in brain of d-galactose mice by Yisui moxibustion
by: Xinge Huang, et al.
Published: (2019-01-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01)

Emerging Therapies for the Myelodysplastic Syndromes
by: Jonathan Canaani
Published: (2019-12-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01)

IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
by: Rosangela Invernizzi, et al.
Published: (2015-04-01)

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry
by: O. Yu. Davydova, et al.
Published: (2019-01-01)

The Differencies in Adult and Pediatric Myelodysplastic Syndrome: A Review
by: Vasekova P, et al.
Published: (2016-08-01)

ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
by: Teresa L Field, et al.
Published: (2010-07-01)

Myelodysplastic syndromes: histopathology as prognostic factor
by: Romeo Maura, et al.
Published: (2001-01-01)

Immune dysregulation in myelodysplastic syndrome
by: Chiharu Sugimori, et al.
Published: (2010-01-01)

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
by: Aya Nakaya, et al.
Published: (2019-11-01)

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
by: Ming-Jing Wang, et al.
Published: (2021-02-01)

Myelodysplastic syndrome: classification and prognostic systems
by: Rosangela Invernizzi, et al.
Published: (2011-12-01)

Treatment of High-risk Myelodysplastic Syndrome
by: LI Shijun, et al.
Published: (2020-12-01)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
by: Julie Schanz, et al.
Published: (2015-04-01)

Myelodysplastic syndromes (MDS): prognostic factors and scoring systems
by: Elizabeth Xisto Souto, et al.

THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM
by: May Basood, et al.
Published: (2018-07-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Abnormal Ferroptosis in Myelodysplastic Syndrome
by: Qi Lv, et al.
Published: (2020-09-01)

Genetics of Myelodysplastic Syndromes
by: Caner Saygin, et al.
Published: (2021-07-01)

Myelodysplastic syndromes: Classification
by: Hans Peter Horny
Published: (2014-01-01)

Myelodysplastic syndromes: Where do we stand?
by: Nitin Sood, et al.
Published: (2016-01-01)

Thalamic Infarction in Myelodysplastic Syndrome (Case Report)
by: Figen Güney, et al.
Published: (2008-02-01)

Genetics and epigenetics of myelodysplastic syndromes and response to drug therapy: new insights
by: Saeid Shahrabi, et al.
Published: (2016-12-01)

The myelodysplastic syndromes: diagnosis, prognosis and therapy
by: Cristina Clissa, et al.
Published: (2013-03-01)

Management of Adult Patients with Myelodysplastic Syndromes
by: Nicolas Bonadies
Published: (2017-08-01)

An analysis of 30 cases of myelodysplastic syndrome
by: Shah Nilam, et al.
Published: (2009-04-01)

Summary of animal models of myelodysplastic syndrome
by: Weisha Li, et al.
Published: (2021-03-01)

Brevundimonas diminuta bacteremia in a man with myelodysplastic syndromes
by: Huiling Cao, et al.
Published: (2015-01-01)

Long-Term Response in a Patient with del(5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge
by: Francesco Pisani, et al.
Published: (2014-04-01)

Gingival enlargement in myelodysplastic syndrome
by: Navia George, et al.
Published: (2015-01-01)

Lymphoblastic transformation of myelodysplastic syndrome
by: Carmen Silvia Passos Lima, et al.

Erythrophagocytosis by neutrophils and megakaryocytic emperipolesis are distinctive morphologic features in del(20q)-associated myelodysplastic syndrome
by: Min Shi, MD, PhD, et al.
Published: (2017-06-01)

DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
by: Matteo Della Porta, et al.
Published: (2017-02-01)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
by: Gattermann, N., et al.
Published: (2022)

INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY
by: Giuseppe Leone, et al.
Published: (2018-07-01)

Myelodysplastic syndrome from theoretical review to clinical application view
by: Amrallah A. Mohammad
Published: (2018-12-01)

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
by: Mohammad Shahjahani, et al.
Published: (2019-02-01)

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
by: Malkan UY, et al.
Published: (2016-03-01)